Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CABG Medical gets rights to Angiotech's cardiovascular IP

Executive Summary

Angiotech (combines drugs, devices, and biomaterials to treat various diseases) has granted CABG Medical (coronary bypass surgery devices) exclusive rights to use its technology that treats restenosis and proliferative diseases with localized delivery of paclitaxel. CABG also gets access to Angiotech's related IP portfolio.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • R+D and Marketing-Licensing
    • Includes Equity

Related Companies